共 18 条
[1]
Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose; voglibose and miglitol in the treatment of type 2 diabetes mellitus.[J].Ranjeet Prasad Dash;R. Jayachandra Babu;Nuggehally R. Srinivas.Xenobiotica.2018, 1
[3]
[5]
Clinical Pharmacokinetics and Pharmacodynamics of Linagliptin.[J].Ulrike Graefe-Mody;Silke Retlich;Christian Friedrich.Clinical Pharmacokinetics.2012, 7
[6]
Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactions..[J].Scheen André J.Clinical pharmacokinetics.2010, 9
[9]
The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly.[J].Kristina Johnell;Inga Klarin.Drug Safety.2007, 10
[10]
Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe.[J].Daniela Fialová;Eva Topinková;Giovanni Gambassi;Harriet Finne-Soveri;Pálmi V. Jónsson;Iain Carpenter;Marianne Schroll;Graziano Onder;Liv Wergeland Sørbye;Cordula Wagner;Jindra Reissigová;Roberto Bernabei;for the AdHOC Project Research Group.JAMA: The Journal of the American Medical Association.2005, 11

